These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36344487)

  • 41. Association of overexpressed proline-directed protein kinase F(A) with chemoresistance, invasion, and recurrence in patients with bladder carcinoma.
    Hsueh SF; Lai MT; Yang CC; Chung YC; Hsu CP; Peng CC; Fu HH; Cheng YM; Chang KJ; Yang SD
    Cancer; 2002 Aug; 95(4):775-83. PubMed ID: 12209721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells.
    Luan T; Fu S; Huang L; Zuo Y; Ding M; Li N; Chen J; Wang H; Wang J
    Exp Cell Res; 2018 Dec; 373(1-2):188-197. PubMed ID: 30463687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutSα/ATM-p73 axis in bladder cancer.
    Zhang H; Xiao X; Wei W; Huang C; Wang M; Wang L; He Y; Sun J; Jiang Y; Jiang G; Zhang X
    Mol Cancer; 2021 Apr; 20(1):70. PubMed ID: 33874956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene Expression Signature of Acquired Chemoresistance in Neuroblastoma Cells.
    Jemaà M; Sime W; Abassi Y; Lasorsa VA; Bonne Køhler J; Michaelis M; Cinatl J; Capasso M; Massoumi R
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer.
    Shi YH; Xu QC; Zhu YQ; Liu ZD; Zhao GY; Liu Q; Wang XY; Wang JQ; Xu X; Su Q; Lai JM; Huang CS; Yin XY
    Mol Ther; 2023 Feb; 31(2):503-516. PubMed ID: 36384875
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism.
    Hashem M; Mohandesi Khosroshahi E; Aliahmady M; Ghanei M; Soofi Rezaie Y; Alsadat Jafari Y; Rezaei F; Khodaparast Eskadehi R; Kia Kojoori K; Jamshidian F; Nabavi N; Rashidi M; Hasani Sadi F; Taheriazam A; Entezari M
    Noncoding RNA Res; 2024 Jun; 9(2):560-582. PubMed ID: 38515791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of anticancer drug resistance using a 3D microfluidic bladder cancer model combined with convolutional neural network-based image analysis.
    Tak S; Han G; Leem SH; Lee SY; Paek K; Kim JA
    Front Bioeng Biotechnol; 2023; 11():1302983. PubMed ID: 38268938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Roles of non-coding RNAs in the metabolism and pathogenesis of bladder cancer.
    Sanya DRA; Onésime D
    Hum Cell; 2023 Jul; 36(4):1343-1372. PubMed ID: 37209205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer.
    Amrutkar M; Gladhaug IP
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cells.
    Mun JY; Baek SW; Jeong MS; Jang IH; Lee SR; You JY; Kim JA; Yang GE; Choi YH; Kim TN; Chu IS; Leem SH
    Cell Death Discov; 2022 Nov; 8(1):450. PubMed ID: 36344487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer.
    Li Y; Zu X; Hu X; Wang L; He W
    Med Sci Monit; 2019 Nov; 25():8928-8939. PubMed ID: 31761897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
    Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
    Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer.
    Lin W; Sun J; Sadahira T; Xu N; Wada K; Liu C; Araki M; Xu A; Watanabe M; Nasu Y; Huang P
    Int J Biol Sci; 2021; 17(12):3255-3267. PubMed ID: 34421363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression.
    Zhang Z; Qiu N; Yin J; Zhang J; Liu H; Guo W; Liu M; Liu T; Chen D; Luo K; Li H; He Z; Liu J; Zheng G
    Theranostics; 2020; 10(10):4290-4307. PubMed ID: 32292495
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.